285 related articles for article (PubMed ID: 26300392)
21. Brimonidine prevents neurodegeneration in a mouse model of normal tension glaucoma.
Semba K; Namekata K; Kimura A; Harada C; Mitamura Y; Harada T
Cell Death Dis; 2014 Jul; 5(7):e1341. PubMed ID: 25032864
[TBL] [Abstract][Full Text] [Related]
22. Arundic acid attenuates retinal ganglion cell death by increasing glutamate/aspartate transporter expression in a model of normal tension glaucoma.
Yanagisawa M; Aida T; Takeda T; Namekata K; Harada T; Shinagawa R; Tanaka K
Cell Death Dis; 2015 Mar; 6(3):e1693. PubMed ID: 25789968
[TBL] [Abstract][Full Text] [Related]
23. Changes of the Retina and Intrinsic Survival Signals in a Rat Model of Glaucoma following Brinzolamide and Travoprost Treatments.
Park HY; Kim JH; Lee DE; Lee JH; Park CK
Ophthalmic Res; 2011 Oct; 46(4):208-17. PubMed ID: 21464578
[TBL] [Abstract][Full Text] [Related]
24. Role of alpha-2 agonists in neuroprotection.
Wheeler L; WoldeMussie E; Lai R
Surv Ophthalmol; 2003 Apr; 48 Suppl 1():S47-51. PubMed ID: 12852434
[TBL] [Abstract][Full Text] [Related]
25. Alpha2 adrenergic receptor-mediated modulation of cytosolic Ca++ signals at the inner plexiform layer of the rat retina.
Dong CJ; Guo Y; Wheeler L; Hare WA
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1410-5. PubMed ID: 17325190
[TBL] [Abstract][Full Text] [Related]
26. Retinal ganglion cell death induced by endoplasmic reticulum stress in a chronic glaucoma model.
Doh SH; Kim JH; Lee KM; Park HY; Park CK
Brain Res; 2010 Jan; 1308():158-66. PubMed ID: 19853589
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a transformed rat retinal ganglion cell line.
Krishnamoorthy RR; Agarwal P; Prasanna G; Vopat K; Lambert W; Sheedlo HJ; Pang IH; Shade D; Wordinger RJ; Yorio T; Clark AF; Agarwal N
Brain Res Mol Brain Res; 2001 Jan; 86(1-2):1-12. PubMed ID: 11165366
[TBL] [Abstract][Full Text] [Related]
28. Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection.
Nizari S; Guo L; Davis BM; Normando EM; Galvao J; Turner LA; Bizrah M; Dehabadi M; Tian K; Cordeiro MF
Cell Death Dis; 2016 Dec; 7(12):e2514. PubMed ID: 27929541
[TBL] [Abstract][Full Text] [Related]
29. Expression of N-methyl-d-aspartate receptor 1 in rats with chronic ocular hypertension.
Kim JH; Lee NY; Jung SW; Park CK
Neuroscience; 2007 Nov; 149(4):908-16. PubMed ID: 17942238
[TBL] [Abstract][Full Text] [Related]
30. Ocular hypotensive effects of topically administered agmatine in a chronic ocular hypertensive rat model.
Hong S; Kim CY; Lee WS; Shim J; Yeom HY; Seong GJ
Exp Eye Res; 2010 Jan; 90(1):97-103. PubMed ID: 19782071
[TBL] [Abstract][Full Text] [Related]
31. The effects of acute intraocular pressure elevation on rat retinal glutamate transport.
Holcombe DJ; Lengefeld N; Gole GA; Barnett NL
Acta Ophthalmol; 2008 Jun; 86(4):408-14. PubMed ID: 18028233
[TBL] [Abstract][Full Text] [Related]
32. Functional assessment of glutamate clearance mechanisms in a chronic rat glaucoma model using retinal ganglion cell calcium imaging.
Hartwick AT; Zhang X; Chauhan BC; Baldridge WH
J Neurochem; 2005 Aug; 94(3):794-807. PubMed ID: 16001970
[TBL] [Abstract][Full Text] [Related]
33. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.
Krupin T; Liebmann JM; Greenfield DS; Ritch R; Gardiner S;
Am J Ophthalmol; 2011 Apr; 151(4):671-81. PubMed ID: 21257146
[TBL] [Abstract][Full Text] [Related]
34. Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.
Katz G; Dubiner H; Samples J; Vold S; Sall K
JAMA Ophthalmol; 2013 Jun; 131(6):724-30. PubMed ID: 23579344
[TBL] [Abstract][Full Text] [Related]
35. Modulation of glutamate transport and receptor binding by glutamate receptor antagonists in EAE rat brain.
Sulkowski G; Dąbrowska-Bouta B; Salińska E; Strużyńska L
PLoS One; 2014; 9(11):e113954. PubMed ID: 25426719
[TBL] [Abstract][Full Text] [Related]
36. Loss of glial fibrillary acidic protein results in decreased glutamate transport and inhibition of PKA-induced EAAT2 cell surface trafficking.
Hughes EG; Maguire JL; McMinn MT; Scholz RE; Sutherland ML
Brain Res Mol Brain Res; 2004 May; 124(2):114-23. PubMed ID: 15135219
[TBL] [Abstract][Full Text] [Related]
37. Müller cell response to laser-induced increase in intraocular pressure in rats.
Woldemussie E; Wijono M; Ruiz G
Glia; 2004 Aug; 47(2):109-19. PubMed ID: 15185390
[TBL] [Abstract][Full Text] [Related]
38. alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia.
Donello JE; Padillo EU; Webster ML; Wheeler LA; Gil DW
J Pharmacol Exp Ther; 2001 Jan; 296(1):216-23. PubMed ID: 11123383
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina.
Baptiste DC; Hartwick AT; Jollimore CA; Baldridge WH; Chauhan BC; Tremblay F; Kelly ME
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2666-76. PubMed ID: 12147601
[TBL] [Abstract][Full Text] [Related]
40. Brimonidine tartrate for the treatment of glaucoma.
Oh DJ; Chen JL; Vajaranant TS; Dikopf MS
Expert Opin Pharmacother; 2019 Jan; 20(1):115-122. PubMed ID: 30407890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
